We are live on ! Find out more
MRVI icon

Maravai LifeSciences
MRVI

206 hedge funds and large institutions have $1.06B invested in Maravai LifeSciences in 2024 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 72 increasing their positions, 70 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

628% more call options, than puts

Call options by funds: $1.51M | Put options by funds: $208K

8.51% more ownership

Funds ownership: 102.55% → 111.06% (+8.5%)

3% more repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 70

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less first-time investments, than exits

New positions opened: 41 | Existing positions closed: 43

2% less funds holding

Funds holding: 210 → 206 (-4)

10% less capital invested

Capital invested by funds: $1.18B → $1.06B (-$122M)

Holders
206
Holders Change
-4
Holders Change %
-1.9%
% of All Funds
2.98%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
41
Increased
72
Reduced
70
Closed
43
Calls
$1.51M
Puts
$208K
Net Calls
+$1.31M
Net Calls Change
-$365K

Top Buyers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
+$35.9M
2
BlackRock
BlackRock
New York
+$28.6M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$18.2M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$18M
5
B
Braidwell
Connecticut
+$15.6M

Top Sellers

Rank Fund Capital Flow
1
First Trust Advisors
First Trust Advisors
Illinois
-$20.8M
2
AQR Capital Management
AQR Capital Management
Connecticut
-$17.7M
3
GL
GTCR LLC
Illinois
-$13.2M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$9.67M
5
Morgan Stanley
Morgan Stanley
New York
-$7.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
EGM
126
Engineers Gate Manager
New York
$175K +$211K +24,400 New
BFG
127
Bleakley Financial Group
New Jersey
$166K -$55.6K -6,442 -22%
SW
128
Simplicity Wealth
New Jersey
$166K -$56K -6,482 -22%
CAM
129
Cresset Asset Management
Illinois
$164K +$8.42K +975 +4%
SEI Investments
130
SEI Investments
Pennsylvania
$148K -$394K -45,593 -69%
JFG
131
Jefferies Financial Group
New York
$122K -$237K -27,500 -62%
Truist Financial
132
Truist Financial
North Carolina
$119K -$4.46K -516 -3%
QT
133
Quantbot Technologies
New York
$117K +$141K +16,377 New
CUAMC
134
China Universal Asset Management Company
China
$112K -$84.9K -9,830 -39%
Public Employees Retirement Association of Colorado
135
Public Employees Retirement Association of Colorado
Colorado
$111K – – –
QC
136
Quent Capital
New York
$109K +$1.38K +160 +1%
HT
137
Headlands Technologies
Illinois
$107K +$86.8K +10,053 +206%
SEC
138
Seven Eight Capital
New York
$105K -$391K -45,341 -76%
Victory Capital Management
139
Victory Capital Management
Texas
$101K -$166K -19,223 -58%
CC
140
Corton Capital
Ontario, Canada
$99.3K +$120K +13,869 New
GC
141
Guggenheim Capital
Illinois
$90.5K +$11.8K +1,364 +12%
ECM
142
Evergreen Capital Management
Washington
$85K -$5.93K -687 -5%
PNC Financial Services Group
143
PNC Financial Services Group
Pennsylvania
$84.6K -$15.2K -1,755 -13%
P
144
Pitcairn
Pennsylvania
$83.2K +$100K +11,624 New
PAM
145
Panagora Asset Management
Massachusetts
$82.4K -$132K -15,258 -57%
Pictet Asset Management
146
Pictet Asset Management
Switzerland
$77.7K – – –
AIP
147
Ameritas Investment Partners
Nebraska
$77.5K +$93.4K +10,821 New
EI
148
Ethic Inc
New York
$74.8K -$29.8K -3,451 -25%
PA
149
Pinnacle Associates
New York
$73.2K – – –
GM
150
GeoWealth Management
Illinois
$60.2K +$72.5K +8,401 New
4 5
6
7 8

MRVI Hedge Fund Activity: Q2 2024 in Review

206 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Maravai LifeSciences (MRVI) for Q2 2024, worth a combined $1.06B — down 10% from $1.18B a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of MRVI and 41 opened new positions — a net loss of 2 holders — while 70 trimmed existing stakes and 72 added.

The largest buyer was Jennison Associates, adding an estimated $35.9M. The largest seller was First Trust Advisors, exiting entirely with an estimated $20.8M sold.

  • 206 institutional investors held Maravai LifeSciences (MRVI) as of Q2 2024, down from 210 in Q1 2024.
  • Funds reported $1.06B of Maravai LifeSciences stock for Q2 2024, down 10% quarter-over-quarter.
  • 41 funds opened new Maravai LifeSciences positions in Q2 2024 and 43 closed out, a net change of -2 holders.
  • The largest Maravai LifeSciences buyer in Q2 2024 was Jennison Associates, an estimated $35.9M added.
  • The largest Maravai LifeSciences seller in Q2 2024 was First Trust Advisors, an estimated $20.8M sold.

Based on aggregated 13F filings for Q2 2024.